United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

napp pharmaceuticals ltd - aminophylline hydrate - modified-release tablet - 350mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - theophylline - modified-release tablet - 200mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - theophylline - modified-release tablet - 300mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - theophylline - modified-release tablet - 400mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

napp pharmaceuticals ltd - aminophylline hydrate - modified-release tablet - 225mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

thornton & ross ltd - diphenhydramine hydrochloride; dextromethorphan hydrobromide - oral solution - 2mg/1ml ; 1.33mg/1ml

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - bazedoxifene acetate; estrogens conjugated - tablets modified release - bazedoxifene acetate 20 mg; estrogens conjugated 0.45 mg - conjugated estrogens and bazedoxifene - treatment of the following conditions in women with a uterus:• treatment of moderate to severe vasomotor symptoms associated with menopause• prevention of postmenopausal osteoporosis

Ireland - English - HPRA (Health Products Regulatory Authority)

ennogen healthcare (europe) limited - theophylline - prolonged-release tablet - xanthines; theophylline

Ireland - English - HPRA (Health Products Regulatory Authority)

ennogen healthcare (europe) limited - theophylline - prolonged-release tablet - xanthines; theophylline

Ireland - English - HPRA (Health Products Regulatory Authority)

ennogen healthcare (europe) limited - theophylline - prolonged-release tablet - xanthines; theophylline